Sue Wang, Partner at Sidley

Today, my guest is Sue Wang, a Partner at Sidley who represents clients across the life sciences industry in high-stakes patent litigation, with a particular emphasis on biologics, cell-based therapies, and related biotechnology. An experienced litigator and trial lawyer, she has helped clients prevail in precedent-setting disputes involving biologics patents against both biosimilars and competitors.

Outside of the courtroom, Sue leverages her litigation experience to counsel clients on patent- and technology-related matters, including patent analysis for technology acquisitions, freedom-to-operate analysis for pipeline products, and strategic planning for future litigation. Sue’s recent experience has involved technologies related to: gene editing; RNA interference; antibody therapeutics; protein manufacturing processes; cancer immunotherapy; and T-cell therapies. Sue earned her J.D. from Stanford Law School and her B.A. from the University of Chicago.